当前位置:首页 - 行情中心 - 回盛生物(300871) - 财务分析

回盛生物

(300871)

  

流通市值:23.31亿  总市值:23.32亿
流通股本:1.66亿   总股本:1.66亿

回盛生物(300871)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.16亿元,每股收益-0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益150978.22万元,未分配利润32553.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产299383.84万元,负债148405.62万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入206,809,092.091,019,758,798.36691,386,248.86449,082,426.69
营业总成本219,314,493.261,016,321,252.34689,038,689.93441,156,049.35
营业利润-21,487,193.8115,082,985.9416,989,09519,616,786.52
利润总额-21,546,000.0612,441,545.6214,640,631.1817,363,212.13
净利润-16,405,616.816,780,818.7714,877,358.4115,897,944.16
其他综合收益----
综合收益总额-16,405,616.816,780,818.7714,877,358.4115,897,944.16
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,277,604,103.831,265,980,935.651,207,394,074.061,326,192,724.79
非流动资产合计1,716,234,324.931,709,479,526.471,703,752,392.531,649,375,636
资产总计2,993,838,428.762,975,460,462.122,911,146,466.592,975,568,360.79
流动负债合计797,276,064.2781,076,484.78722,157,861.13801,327,239.87
非流动负债合计686,780,177.54685,102,915.22681,673,638.27665,905,634.78
负债合计1,484,056,241.741,466,179,4001,403,831,499.41,467,232,874.65
归属于母公司股东权益合计1,509,782,187.021,509,281,062.121,507,314,967.191,508,335,486.14
股东权益合计1,509,782,187.021,509,281,062.121,507,314,967.191,508,335,486.14
负债和股东权益合计2,993,838,428.762,975,460,462.122,911,146,466.592,975,568,360.79
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计224,327,944.231,081,594,132.55744,551,814.05515,413,798.18
经营活动现金流出小计270,607,437.88988,674,786.55687,491,600.93509,392,256.7
经营活动产生的现金流量净额-46,279,493.6592,919,34657,060,213.126,021,541.48
投资活动现金流入小计183,452,284.71,069,533,807.36753,246,841.44584,866,399.3
投资活动现金流出小计259,784,477.071,169,837,876.12928,448,613.39701,311,407.85
投资活动产生的现金流量净额-76,332,192.37-100,304,068.76-175,201,771.95-116,445,008.55
筹资活动现金流入小计202,776,473264,767,475.65234,000,720208,628,706.9
筹资活动现金流出小计107,572,170.13306,243,839.45275,054,353.66166,559,124.63
筹资活动产生的现金流量净额95,204,302.87-41,476,363.8-41,053,633.6642,069,582.27
汇率变动对现金及现金等价物的影响-355,524.4-232,826.75154.9812,560.54
现金及现金等价物净增加额-27,762,907.55-49,093,913.31-159,195,037.51-68,341,324.26
期末现金及现金等价物余额201,749,381.84229,512,289.39119,411,165.19210,264,878.44
最新报告期:2024-04-25
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
民生证券徐菁0.420.711.072024-04-25
TOP↑